Industry and Research Foundations
TIF collaborates with a network of pharmaceutical companies and research foundations that share a common interest in thalassemia, haemoglobin disorders and rare anaemias and in the development of technologies and drugs for the prevention, treatment and monitoring of these diseases.
The Thalassaemia International Federation (TIF) prioritizes transparency in its collaborations with pharmaceutical industry partners to ensure ethical standards and mutual trust. By maintaining open lines of communication and sharing data responsibly, TIF seeks to align the objectives of its partners with the needs of patients and healthcare communities.
Read more HERE.
TIF thanks the following partners (in alphabetical order) for their continued support of the Federation’s mission to promote knowledge and implement national control programmes for the prevention and treatment of thalassaemia and other haemoglobin disorders in all affected countries.
